longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

600721

600721
----

LongbridgeAI

The concept of weight loss drugs continues to strengthen, BHC hits the daily limit

Zhitong
Aug 18, 2025 at 01:59 AM

The concept of weight loss drugs continues to strengthen, BHC hits the limit up, and Hanyu Pharmaceutical, Jinkai Biotechnology, Shengnuo Biotech, Keyuan Pharmaceutical, ST Nuotai, Lepu Medical, and others follow suit

Source: Zhitong The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

BHC

BHC

600721.SH

Open

--

High

--

Low

--

Prev Close

--

P/ETTM

--

Market Cap

--